Related Experiment Video

Updated: Aug 6, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Inhibition of prostate cancer growth by estramustine and colchicine

M Fakih1, A Yagoda, T Replogle

  • 1Meyer L. Prentis Comprehensive Cancer Center, Wayne State University School of Medicine, Detroit, Michigan, USA.

The Prostate
|June 1, 1995
PubMed

Insights

Estramustine and colchicine, microtubule inhibitors, show cytotoxicity against hormone-refractory prostate cancer cells. While both agents inhibit tumor growth in vivo, their combination did not yield additive effects, warranting further investigation for oral colchicine use.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Hormone-refractory prostate cancer (HRPC) presents a significant clinical challenge with a poor prognosis.
  • Microtubule-targeting agents have demonstrated cytotoxic effects on prostate cancer cells in various settings.
  • Estramustine and colchicine are established microtubule inhibitors with potential therapeutic applications.

Purpose of the Study:

  • To evaluate the efficacy of estramustine and colchicine as single agents and in combination against hormone-refractory prostate cancer.
  • To investigate the in vitro and in vivo mechanisms of action of these microtubule inhibitors in prostate cancer models.

Main Methods:

  • Cytotoxicity assays were performed using the Dunning rat prostate adenocarcinoma cell line (MLL) and human prostate cancer cells (PC-3).
  • In vitro assessments included motility and cell cycle analysis to evaluate microtubule function.
  • In vivo studies involved implanting MLL cells in rats to assess the tumor growth inhibition by estramustine and colchicine.

Main Results:

  • The combination of estramustine and colchicine exhibited cytotoxicity against both MLL and PC-3 cells at clinically achievable concentrations.
  • In vitro, both agents inhibited cellular motility but did not significantly affect cell cycle progression.
  • In vivo, estramustine and colchicine individually inhibited the growth of implanted MLL tumors, but no additive effects were observed.

Conclusions:

  • Estramustine and colchicine demonstrate cytotoxic activity against hormone-refractory prostate cancer cells.
  • The agents primarily impact cellular motility rather than cell cycle transit.
  • Further research into the potential of oral colchicine for treating hormone-refractory prostate cancer is warranted.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...